[{"Assets_0_Q3_USD":687200000.0,"CommonStockSharesOutstanding_0_Q3_shares":48617989.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-210778000.0,"NetIncomeLoss_1_Q3_USD":-77137000.0,"NetIncomeLoss_3_Q3_USD":-226385000.0,"StockholdersEquity_0_Q3_USD":449806000.0,"Ticker":"AGIO","CIK":"1439222","name":"AGIOS PHARMACEUTICALS INC","OfficialName":"Agios Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1422760526.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171101"}]